RA Capital Management »

Bicycle Therapeutics shares owned by RA Capital Management

Quarter-by-quarter ownership of Bicycle Therapeutics (BCYC) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Bicycle Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicycle Therapeutics held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicycle Therapeutics by RA Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 800k 18.08
2023-09-30 $16M 800k 20.09

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Immunogen SH
Vaxcyte SH (PCVX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Aerovate Therapeutics SH (AVTE)
Inhibrx SH (INBX)
Cymabay Therapeutics SH
Biogen SH (BIIB)
Rxsight SH (RXST)
89bio SH (ETNB)
Verona Pharma Plc - SH (VRNA)
Day One Biopharmaceuticals I SH (DAWN)
An2 Therapeutics SH (ANTX)
Tyra Biosciences SH (TYRA)

View all positions for RA Capital Management

Top funds holding Bicycle Therapeutics

Paradigm Biocapital Advisors
Baker Bros. Advisors
First Light Asset Management
Westfield Capital Management Company
Candriam Luxembourg S.C.A.
Ridgeback Capital Investments
RA Capital Management
Bnp Paribas Investment Partners
Bank of America Corporation
Kennedy Capital Management
Nomura Holdings
Citadel Advisors
T. Rowe Price Associates
Millennium Management
Point72 Asset Management

View all funds holding Bicycle Therapeutics